|
12.06.25 - 09:30
|
NKT strengthens offshore power cable installation with the world′s most powerful subsea trencher (Cision)
|
|
NKT invests in the powerful subsea trencher NKT T3600 to enhance the protection of power cable infrastructure, which is critical to ensuring the security of supply and the transition to renewable energy. This investment is further supported by UK-based suppliers and strengthens NKT's complete cable solutions for reliable project execution with greater performance whilst reducing risk.
Press Release
12 June 2025
To meet the high demand for high-voltage power cables needed for renewable energy, NKT is investing in manufacturing and installation capabilities, including the NKT Eleonora, a...
|
|
12.06.25 - 08:06
|
Peab builds new dock in Karlskrona (Cision)
|
|
Peab has been commissioned to build a new dock in Karlskrona. The customer is NKT HV Cables AB and the contract is worth SEK 250 million.
The project is part of NKT's ongoing expansion of its high voltage cable factory in Karlskrona and comprises construction of a sheet pile dock, a pile deck dock and a dolphin, adapted for a new cable-laying vessel that NKT has ordered for its operations. The contract also includes dredging as well as new construction of and rebuilding water, sewage and electricity facilities.
"We look forward to this important contract that will improve the port. This...
|
|
11.06.25 - 08:36
|
Rebranding SolidAl to NKT: A natural step towards a unified future (Cision)
|
|
NKT announces the rebranding of SolidAl to NKT, marking the next step in the successful integration of the medium- and high-voltage power cable factory in Esposende, Portugal.
In June 2024, NKT acquired SolidAl in Esposende, Portugal to meet the robust demand from grid upgrades and renewable energy projects across Europe. Since then, the integration has progressed as planned and bringing the site under the NKT brand is a natural next step towards a unified, global approach.
The rebranding will support a consistent go-to-market strategy, strengthening NKT in Portugal, Spain, France,...
|
|
|
|
|
06.05.25 - 13:42
|
NKT names its new tower at the high-voltage factory in Karlskrona (Cision)
|
|
NKT has revealed the name of its third extrusion tower at the Swedish high-voltage power cable factory in Karlskrona. The tower, now called NKT Crown, rises 200 meters above the city, symbolising NKT's substantial investments in the factory and the positive development of Karlskrona.
The new tower, NKT Crown, is a significant part of the ongoing expansion of NKT's high-voltage cable factory in Karlskrona, Sweden, to meet the robust demand for high-voltage power cables. NKT Crown rises 200 meters into the sky, creating a new skyline in Karlskrona alongside NKT's two other towers. The tower...
|
|
29.04.25 - 07:18
|
NKT signs EUR 1 billion supply agreement with Hydro for low-carbon aluminium wire rod through to 2033 (Cision)
|
|
The agreement will ensure security of supply of a critical raw material from a European partner, support NKT's decarbonisation journey and enhance the sustainability of medium- and high-voltage power cable solutions.
NKT has signed a landmark supply agreement with Hydro to secure a long-term supply of low-carbon aluminium wire rod through to 2033, with an estimated contract value of approximately EUR 1 billion, depending on the quantity, duration options and future metal prices.This agreement plays a crucial role in NKT's ongoing decarbonisation efforts, enabling the company to deliver power...
|
|
16.04.25 - 14:36
|
GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference (GlobeNewswire EN)
|
|
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that its abstract has been selected for poster presentation in a poster discussion session at the 2025 ATS International Conference being held May 18-21, 2025 in San Francisco, CA.Details of the presentation are as follows:Title: Inactivation of iNKT Cells After the Inflammatory Phase Leads to Significant Inhibition of Fibroblast Activation and Fibrosis in a Model of Pulmonary FibrosisPoster Board Number: 810Presenter: Marc Hertz, PhD, Chief Executive Officer of GRI BioSession: D21 - IMMUNOLOGICAL INSIGHTS IN LUNG INFLAMMATION AND REPAIRDate and Time: Wednesday, May 21, 2025 from 8:15-10:15 AM PTLocation: Room 2022/2024 (West Building, Level 2), Moscone CenterFor more information about the 2025 ATS Inter...
|
|
03.04.25 - 12:30
|
NKT expansion in Karlskrona becomes the first European net-zero strategic project (Cision)
|
|
The EU has recognised the expansion of NKT's high-voltage power cable factory in Karlskrona as the first European net-zero strategic project under the EU Net-Zero Industry Act. This status provides the project with a national priority status for accelerated administrative treatment and faster permitting.
To meet the high demand for high-voltage power cables, NKT is investing substantially in expanding its high-voltage factory in Karlskrona, Sweden. This will make the site the world's largest manufacturing facility for high-voltage offshore power cables. The expansion has now been recognized...
|
|
02.04.25 - 22:06
|
GRI Bio Announces Closing of $5.0 Million Public Offering (GlobeNewswire EN)
|
|
LA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced the closing of its previously announced public offering of an aggregate of 1,388,888 shares of its common stock (or common stock equivalents in lieu thereof), Series E-1 warrants to purchase up to 1,388,888 shares of common stock, short-term Series E-2 warrants to purchase up to 1,388,888 shares of common stock and short-term Series E-3 warrants to purchase up to 1,388,888 shares of common stock (all the warrants, collectively, the "Series Warrants"), at a combined public offering price of $3.60 per share (or per common stock equivalent in lieu thereof) and accompanying Series Warrants. The Series Warrants have an exercise price of $3.20 per share and are exercisable immediately upon issuance. ...
|
|
02.04.25 - 08:01
|
Assemblin secures new multi-technical assignment from NKT (Cision)
|
|
Assemblin Electrical, Heating & Sanitation, Ventilation and Sprinklers have signed an agreement with Skanska and NKT, the end customer, regarding installations in the new cable tower in Karlskrona, Sweden. The cable tower is NKT's third extrusion tower and all the Assemblin Swedish Business Areas will participate.
All of Assemblin's Swedish Business Areas were also involved in the work on the second tower, which was completed in 2022. The new tower, the foundations for which began to be laid in May 2023, will be NKT's third and tallest tower. At a depth of 15 meters below ground and a height...
|
|
01.04.25 - 17:18
|
GRI Bio Announces Pricing of $5.0 Million Public Offering (GlobeNewswire EN)
|
|
LA JOLLA, CA, April 01, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced the pricing of a public offering of an aggregate of 1,388,888 shares of its common stock (or common stock equivalents in lieu thereof), Series E-1 warrants to purchase up to 1,388,888 shares of common stock, short-term Series E-2 warrants to purchase up to 1,388,888 shares of common stock and short-term Series E-3 warrants to purchase up to 1,388,888 shares of common stock (all the warrants, collectively, the "Series Warrants"), at a combined public offering price of $3.60 per share (or per common stock equivalent in lieu thereof) and accompanying Series Warrants. The Series Warrants will have an exercise price of $3.20 per share and will be exercisable immediately upon issuance. The Series E-1...
|
|
|
|
17.03.25 - 07:31
|
NKT launches new monitoring solution to safeguard cables (Cision)
|
|
NKT introduces an integrated cable monitoring platform designed to support continuous operation of on- and offshore power cables by proactively identifying and mitigating potential threats, including fishing accidents and deliberate damage.
NKT is launching a new cable monitoring solution, a platform that integrates multiple sensors and combines technologies to provide a comprehensive overview of power cable conditions, aiming to make power cable grids more reliable.
The platform combines data from various sensors and technologies, such as vessel location, acoustic sensing around the...
|
|
11.03.25 - 13:39
|
GRI Bio Regains Compliance with Nasdaq′s Minimum Bid Price Rule (GlobeNewswire EN)
|
|
LA JOLLA, CA, March 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that it received notice on March 10, 2025 from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with Nasdaq Listing Rule 5550(a)(2), also known as the “minimum bid price rule.”...
|
|
|
|
21.02.25 - 13:01
|
NKT Aktie: Langfristig bleibt die Story sicherlich spannend, aber... (Aktiencheck)
|
|
Kulmbach (www.aktiencheck.de) - NKT-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie der NKT A/S (ISIN: DK0010287663, WKN: 861226, Ticker-Symbol: NKT, NASDAQ Kopenhagen-Symbol: NKT) unter die Lupe.
Der dänische Hersteller von Starkstromkabeln könne mit seinen Zahlen zum vierten Quartal respektive Fiskaljahr 2024 nicht überzeugen. [mehr]...
|
|